Patients with a high risk of developing lung cancer now have a better chance at early detection with low dose CT screening. GE Healthcare (Chalfont, UK) said it is now the first company with a low-dose CT (LDCT) technology that is FDA cleared for lung cancer screening. Some physicians have already been using LDCT for lung cancer screening off label. Read More
